Calamos Wealth Management LLC Bristol Myers Squibb CO Transaction History
Calamos Wealth Management LLC
- $1.93 Billion
- Q4 2024
A detailed history of Calamos Wealth Management LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Calamos Wealth Management LLC holds 11,123 shares of BMY stock, worth $599,529. This represents 0.03% of its overall portfolio holdings.
Number of Shares
11,123
Previous 10,853
2.49%
Holding current value
$599,529
Previous $561,000
12.12%
% of portfolio
0.03%
Previous 0.03%
Shares
22 transactions
Others Institutions Holding BMY
# of Institutions
2,729Shares Held
1.57BCall Options Held
30MPut Options Held
31.7M-
Vanguard Group Inc Valley Forge, PA190MShares$10.2 Billion0.19% of portfolio
-
Black Rock Inc. New York, NY159MShares$8.55 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY96MShares$5.18 Billion0.44% of portfolio
-
State Street Corp Boston, MA95.1MShares$5.13 Billion0.22% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA60.3MShares$3.25 Billion0.65% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $115B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...